Otonomy

- NASDAQ:OTIC
Last Updated 2021-07-30
  • Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
  • Locations

    • San Diego CA
  • Total Funding (USD)

    143.4 million
  • Industries

    Real Estate, Mobile Apps
  • Security

    Type: ORD
    CUSIP: 68906L105
    ISIN: US68906L1052
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.